Bristol Myers Squibb (CELG-RI) Intangibles (2009 - 2026)

Bristol Myers Squibb (CELG-RI) reported Intangibles of $18.2 billion for Q1 2026, down 18.87% year-over-year from $22.5 billion in Q1 2025, and down 4.5% quarter-over-quarter from $19.1 billion in Q4 2025.

Bristol Myers Squibb (CELG-RI) Intangibles (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (CELG-RI) has 18 years of Intangibles data on file, last reported at $18.2 billion in Q1 2026.

  • Intangibles for Q1 2026 came in at $18.2 billion, down 18.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.2 billion (down 18.87% YoY), and the FY2025 annual result was $19.1 billion, down 18.04% from the prior year.
  • Intangibles declined to $18.2 billion in Q1 2026 per CELG-RI's latest filing, from $19.1 billion in the prior quarter.
  • Over five years, Intangibles peaked at $40.1 billion in Q1 2022 and troughed at $18.2 billion in Q1 2026.
  • A 5-year average of $28.6 billion and a median of $29.0 billion in 2023 frame the typical range for Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Intangibles retreated 2.41% in 2024, then plunged 31.36% in 2025.
  • A 5-year view of Intangibles shows it stood at $35.9 billion in 2022, then retreated by 24.5% to $27.1 billion in 2023, then dropped by 13.91% to $23.3 billion in 2024, then dropped by 18.04% to $19.1 billion in 2025, then declined by 4.5% to $18.2 billion in 2026.
  • Business Quant data shows CELG-RI's Intangibles at $18.2 billion in Q1 2026, $19.1 billion in Q4 2025, and $20.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 24.45 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 7.37 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 49.06 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 50.87 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 25.75 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 21.38 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 16.38 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 52.56 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 18.24 Bn
10 Bristol Myers Squibb - - 8.07 Bn 18.24 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.24 Bn
Dec 31, 2025 19.10 Bn
Sep 30, 2025 20.47 Bn
Jun 30, 2025 21.38 Bn
Mar 31, 2025 22.49 Bn
Dec 31, 2024 23.31 Bn
Sep 30, 2024 26.96 Bn
Jun 30, 2024 29.43 Bn
Mar 31, 2024 32.76 Bn
Dec 31, 2023 27.07 Bn
Sep 30, 2023 28.95 Bn
Jun 30, 2023 31.30 Bn
Mar 31, 2023 33.57 Bn
Dec 31, 2022 35.86 Bn
Sep 30, 2022 38.18 Bn
Jun 30, 2022 37.69 Bn
Mar 31, 2022 40.10 Bn
Dec 31, 2021 42.53 Bn
Sep 30, 2021 44.93 Bn
Jun 30, 2021 48.07 Bn